Whitebox Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-552,490
Closed -$54.9M 110
2019
Q3
$54.9M Sell
552,490
-64,314
-10% -$6.11M 1.99% 10
2019
Q2
$57M Buy
616,804
+101,522
+20% +$9.64M 2.01% 8
2019
Q1
$48.6M Buy
+515,282
New +$45.1M 1.48% 10
2015
Q1
Sell
-86,462
Closed -$9.67M 481
2014
Q4
$9.67M Sell
86,462
-91,943
-52% -$9.7M 0.39% 58
2014
Q3
$16.9M Sell
178,405
-10,595
-6% -$956K 0.66% 32
2014
Q2
$16.2M Buy
189,000
+167,050
+761% +$12.7M 0.64% 35
2014
Q1
$1.53M Buy
21,950
+5,362
+32% +$425K 0.07% 232
2013
Q4
$1.4M Buy
+16,588
New +$1.31M 0.06% 229

Other funds holding CELG

Whitebox Advisors's CELG Position: Q4 2019 in Review

Whitebox Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 552,490 shares — an estimated $54.9M sold.

Whitebox Advisors first reported a position in CELG in Q4 2013 and held it in 8 quarters. The position peaked at $57M in Q2 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Whitebox Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Whitebox Advisors sold 552,490 Celgene Corp shares in Q4 2019, an estimated $54.9M.
  • Whitebox Advisors first reported a position in Celgene Corp in Q4 2013 and held it in 8 quarters.
  • Whitebox Advisors's Celgene Corp position peaked at $57M in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Whitebox Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.